|
|
|
|
Base effect subdues pharma market's growth in Feb
|
|
|
|
| Top Stories |
 |
|
|
|
SME Times News Bureau | 06 Mar, 2021
High base effect along with volume decline subdued the growth of India's
pharmaceuticals market, India Ratings and Research (Ind-Ra) said.
Accordingly, the volume declined in the anti-infective and respiratory products was pronounced during the month.
"Ind-Ra
expects a growth improvement over the coming months as the vaccination
drive gains momentum and a lower base leads to better growth momentum."
"However,
IPM grew 1.1 per cent YoY during February 2021, due to a 5.8 per cent
volume decline, price growth of 4.8 per cent and products launches at
2.1 per cent."
According to Ind-Ra, acute therapies such as
gastro and vitamins witnessed sales growth of 9.9 per cent YoY and 8.6
per cent YoY, respectively, while anti-infectives declined 11.3 per cent
YoY during February 2021.
"A growth outperformance was observed
in chronic therapies during the month, with cardiac and anti-diabetic
growing 7.3 per cent YoY and 4.3 per cent YoY, respectively."
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Customs Exchange Rates |
| Currency |
Import |
Export |
US Dollar
|
₹95.3
|
₹93.6 |
UK Pound
|
₹127.7
|
₹123.7 |
Euro
|
₹110.65
|
₹106.9 |
| Japanese
Yen |
₹59.75 |
₹57.9 |
| As on 24 Jun, 2026 |
|
|
| Daily Poll |
 |
 |
| What’s your biggest challenge with the 45-day payment rule? |
|
|
|
|
|
| Commented Stories |
|
|
|
|
|
|
| |
|
